AR048449A1 - Pirazoles cristalinos - Google Patents

Pirazoles cristalinos

Info

Publication number
AR048449A1
AR048449A1 ARP050101229A ARP050101229A AR048449A1 AR 048449 A1 AR048449 A1 AR 048449A1 AR P050101229 A ARP050101229 A AR P050101229A AR P050101229 A ARP050101229 A AR P050101229A AR 048449 A1 AR048449 A1 AR 048449A1
Authority
AR
Argentina
Prior art keywords
prazols
crystal
crystals
interconversion
benzenesulfonamide
Prior art date
Application number
ARP050101229A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AR048449A1 publication Critical patent/AR048449A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04W—WIRELESS COMMUNICATION NETWORKS
    • H04W16/00—Network planning, e.g. coverage or traffic planning tools; Network deployment, e.g. resource partitioning or cells structures
    • H04W16/18—Network planning tools
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04W—WIRELESS COMMUNICATION NETWORKS
    • H04W24/00—Supervisory, monitoring or testing arrangements
    • H04W24/02—Arrangements for optimising operational condition

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se refiere a formas de cristales de 4-[5-(4-fluorfenil)-3-(trifluormetil)-1H-pirazol-1-il]-bencensulfonamida y métodos para la preparacion, interconversion y aislamiento de dichos cristales.
ARP050101229A 2004-04-01 2005-03-30 Pirazoles cristalinos AR048449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55846904P 2004-04-01 2004-04-01

Publications (1)

Publication Number Publication Date
AR048449A1 true AR048449A1 (es) 2006-04-26

Family

ID=34961629

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101229A AR048449A1 (es) 2004-04-01 2005-03-30 Pirazoles cristalinos

Country Status (25)

Country Link
US (2) US7652149B2 (es)
EP (1) EP1742922B1 (es)
JP (1) JP4177883B2 (es)
KR (1) KR100820511B1 (es)
CN (1) CN1938276B (es)
AR (1) AR048449A1 (es)
AU (1) AU2005227745C1 (es)
BR (1) BRPI0509506A8 (es)
CA (1) CA2562104C (es)
DK (1) DK1742922T3 (es)
EA (1) EA008697B1 (es)
ES (1) ES2565409T3 (es)
HK (1) HK1099755A1 (es)
HU (1) HUE028811T2 (es)
IL (1) IL177711A0 (es)
MA (1) MA28494B1 (es)
NO (1) NO20064986L (es)
NZ (1) NZ550907A (es)
PL (1) PL1742922T3 (es)
SI (1) SI1742922T1 (es)
TN (1) TNSN06313A1 (es)
TW (1) TW200536816A (es)
UA (1) UA84455C2 (es)
WO (1) WO2005095349A1 (es)
ZA (1) ZA200607154B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2565409T3 (es) * 2004-04-01 2016-04-04 Zoetis Services Llc Derivado de pirazol cristalino
US8440709B2 (en) 2005-12-14 2013-05-14 Makhteshim Chemical Works Ltd. Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile
EA018341B1 (ru) 2006-11-10 2013-07-30 Басф Се Новая кристаллическая модификация фипронила и ее применение
PT2083629E (pt) 2006-11-10 2011-09-01 Basf Se Modificação cristalina de fipronil
UA110598C2 (uk) 2006-11-10 2016-01-25 Басф Се Спосіб одержання кристалічної модифікації фіпронілу
JP2017081860A (ja) * 2015-10-29 2017-05-18 株式会社トクヤマ セレコキシブの製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2078447T3 (es) 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US6492411B1 (en) * 1993-11-30 2002-12-10 G. D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
CA2234633A1 (en) 1995-10-17 1997-04-24 G.D. Searle & Co. Method of detecting cyclooxygenase-2
US6083986A (en) 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6221153B1 (en) 1998-06-09 2001-04-24 Trevor Percival Castor Method for producing large crystals of complex molecules
US6787154B2 (en) 1998-10-20 2004-09-07 Salvatore Albani Artificial antigen presenting cells
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
TR200001872A3 (tr) * 2000-06-26 2002-01-21 Fako Ilaclari A.S 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.
ES2565409T3 (es) * 2004-04-01 2016-04-04 Zoetis Services Llc Derivado de pirazol cristalino

Also Published As

Publication number Publication date
KR20060131949A (ko) 2006-12-20
AU2005227745C1 (en) 2009-02-26
WO2005095349A1 (en) 2005-10-13
BRPI0509506A (pt) 2007-09-18
HUE028811T2 (en) 2017-01-30
NZ550907A (en) 2010-10-29
TNSN06313A1 (fr) 2007-12-03
TW200536816A (en) 2005-11-16
HK1099755A1 (en) 2007-08-24
DK1742922T3 (en) 2016-04-11
SI1742922T1 (sl) 2016-07-29
PL1742922T3 (pl) 2016-06-30
CA2562104A1 (en) 2005-10-13
UA84455C2 (en) 2008-10-27
BRPI0509506A8 (pt) 2017-01-24
EA200601601A1 (ru) 2007-02-27
CN1938276B (zh) 2011-08-10
JP2007530655A (ja) 2007-11-01
CA2562104C (en) 2010-08-17
CN1938276A (zh) 2007-03-28
ES2565409T3 (es) 2016-04-04
US20100093820A1 (en) 2010-04-15
EA008697B1 (ru) 2007-06-29
IL177711A0 (en) 2006-12-31
ZA200607154B (en) 2008-03-26
KR100820511B1 (ko) 2008-04-11
JP4177883B2 (ja) 2008-11-05
US20050222240A1 (en) 2005-10-06
US7652149B2 (en) 2010-01-26
MA28494B1 (fr) 2007-03-01
EP1742922A1 (en) 2007-01-17
AU2005227745B2 (en) 2008-05-29
EP1742922B1 (en) 2016-02-03
AU2005227745A1 (en) 2005-10-13
NO20064986L (no) 2006-12-21

Similar Documents

Publication Publication Date Title
NO20053215D0 (no) Pyrazolderivater med anvendelse som COX-1-inhibitorer.
EA201000145A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
DK1496912T3 (da) Kombination af brimonidin og timolol til topisk, ophthalmisk anvendelse
AR048449A1 (es) Pirazoles cristalinos
BRPI0920598A2 (pt) formas sólidas de n-(4(7-azabiciclo[2.2.1]heptan-7-il)-2-(triflúor-metil)fenil)-4-oxo-5-(triflúor-metil)-1,4-di-hidroquinolina-3-carboxamida
CL2007000601A1 (es) Compuestos derivados de heterobiciclos pirazolicos, inhibidores de la actividad de proteina tiroxina quinasa; composicion farmaceutica que comprende dichos compuestos; y uso de los compuestos en el tratamiento de una enfermedad hiperproliferativa.
MA28739B1 (fr) Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer
UY33397A (es) Forma sólida de un naftaleno carboxamida
DK1720550T3 (da) Derivater af piperidinylalkylcarbamater, fremstilling heraf samt anvendelse heraf som inhibitorer for FAAH enzym
MA28822B1 (fr) Benzamides substitues trifluoromethyle comme inhibiteurs de kinase
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
DK3724191T3 (da) 5-(2-(2,5-difluorphenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazol[1,5-a]pyrimidinderivater og lignende forbindelser som trk-kinasehæmmere til cancerbehandling
WO2008058285A3 (en) 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
DK1799649T3 (da) 3-(2-hydroxyphenyl)-pyrazoler og deres anvendelse som hsp90-modulatorer
DE602004008227D1 (de) Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase
EA200300067A1 (ru) Кристаллическая форма целекоксиба
EA200801413A1 (ru) Гетероциклические сетр ингибиторы
CL2011003138A1 (es) N-(protegido- n-(3-metoxi-5-metilpirazon-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridino-3-sulfonamida y su proceso de preparacion.
AR046131A1 (es) Formas cristalinas de {2-[1-(3,5- bistrifluorurometilbencil)-5- piridin-4-il-1h-[1,2,3]triazol- 4-il]piridin- 3-il}-(2-clorofenil)metanona
NO20052813L (no) Celecoxib-promedikament
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5
WO2003047517A3 (en) Novel-n-[4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa
WO2006079923A3 (en) Form iv crystalline celecoxib
CL2008002058A1 (es) Metodo para la preparacion de trifluoralquil-fenil-sulfonamidas y de sulfonamidas heterociclicas usando n-trifluoroacteilmorfolina; su metodo de preparacion y su uso.
CY1110942T1 (el) Αλας αιθανολαμινης n-(3-μεθοξυ-αιθοξυ-5-μεθυλπυραζιν-2-υλ)-2-(4-[1,3,4-οξαδιαζολο -2-υλ]φαινυλ)πυριδινο-3-σουλφοναμιδιου

Legal Events

Date Code Title Description
FA Abandonment or withdrawal